Weight loss accelerates in months two through six
Which GLP-1 RAs are currently available
Start here: a simple, practical guide The Weight Loss Trio: Understanding Muscle Loss, Appetite, and Nausea on GLP-1s Understand why GLP-1 medications cause muscle loss, appetite suppression, and nausea, and how to manage GLP-1 Agonists and Sleep Disorders: How the Treatment Protocol Changed OSA is the most clinically well-studied sleep disorder in the GLP-1 space and the one GLP-1 and Fatty Liver Disease: What the Trial Data Keeps Showing Beyond Weight Loss GLP-1 agonists improve fatty liver through direct hepatic mechanisms, not just weight loss
Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency
In studies, participants lost an average of 15% to 22.5% of their initial body weight over 72 weeks, depending on the dosage
4.- EFSA Journal 2010;8(10):1758